TCT 1620: First-in-Human Use of an Oscor Breezeway Adelente Catheter to Optimize Support During the Implantation of an A-Flux Device in a Challenging Anatomy
We Recommend
Disclosures
<p>Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: </p><ul><li>Consultant Fee/Honoraria/Speaker's Bureau - Boston Scientific Corporation; Edwards Lifesciences</li></ul>